<DOC>
	<DOCNO>NCT02912169</DOCNO>
	<brief_summary>The intent clinical study answer question : 1 ) Is propose treatment safe 2 ) Is treatment effective improve disease pathology patient Alzheimer 's Disease clinical outcome ?</brief_summary>
	<brief_title>Study Assess Safety Effects Autologous Adipose-Derived Stromal Cells Patients With Alzheimer 's Disease</brief_title>
	<detailed_description>Autologous Adipose-derived Stromal Vascular Fraction ( AD-SVF ) infuse intra-venous Intra nasal . The therapy compose cell derive patient ' adipose tissue isolate within approximately 1 hour immediately deliver back patient .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Males female , age 55 old Diagnosis probable Alzheimer 's disease , consistent criterion : 1 ) National Institute Neurological Communicable Disease Stroke Alzheimer 's Disease Related Disorders Association ( NINCDSADRDA ) 2 ) Diagnostic Statistical Manual Mental Disorders ( DSM IV ) Up date age gender appropriate cancer screen per American Cancer Society ( Refer section 9.3 detail ) . Females pregnant nursing female childbearing potential unwilling maintain contraceptive therapy duration study Life expectancy &lt; 6 month due concomitant illness . Exposure investigational drug procedure within 1 month prior study entry enrol concurrent study may confound result study . Active infectious disease . For patient test positive HIV , HTLV , HBV , HCV , CMV ( IgM &gt; IgG ) and/or syphilis , expert consult patient eligibility base patient 's infectious status Any illness , Investigator 's judgment , interfere patient 's ability comply protocol , compromise patient safety , interfere interpretation study result Patients chronic immunosuppressive transplant therapy Systolic blood pressure ( supine ) â‰¤90 mmHg ; Resting heart rate &gt; 100 bpm ; Active clinical infection . Cerebrovascular accident within 6 month prior study entry Known drug alcohol dependence factor interfere study conduct interpretation result opinion investigator suitable participate . History cancer ( nonmelanoma skin cancer insitu cervical cancer ) last five year . Patient legal guardian applicable u unwilling and/or able give write informed consent . Dementia due condition AD , include vascular dementia</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>Alzheimer 's</keyword>
	<keyword>Stem cell</keyword>
	<keyword>Adipose-derived stem cell</keyword>
	<keyword>ASC</keyword>
	<keyword>ADSC</keyword>
</DOC>